Purple Biotech (PPBT) Stock Statistics & Valuation Metrics

Purple Biotech has a market cap or net worth of 24.99M. The enterprise value is -191.77K.

Purple Biotech has 567,961,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Purple Biotech’s return on equity (ROE) is -0.22 and return on invested capital (ROIC) is -33.11%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Purple Biotech had revenue of 0.00 and earned -7.24M in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -14.37M and capital expenditures 0.00, giving a free cash flow of -14.37M billion.

Purple Biotech pays an annual dividend of 249.549, resulting in a dividend yield of ―

Purple Biotech upcoming earnings date is Aug 14, 2025, TBA (Confirmed).

Purple Biotech as a current ratio of 2.23, with Debt / Equity ratio of 0.56%

In the past 12 months, Purple Biotech has paid 0.00 in taxes.

Purple Biotech EV to EBITDA ratio is 0.92, with an EV/FCF ratio of 0.45.

Purple Biotech has 8.52M in cash and marketable securities with $183.00K in debt, giving a net cash position of -8.34M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Purple Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―